[
  {
    "paper_title": "Paper 1",
    "gene": "PHOX2B",
    "protein": "Transcription factor",
    "variant": "p.R98W",
    "assay_type": "Enzyme activity assay",
    "controls": {
      "basic_controls": [
        "wild-type protein",
        "known loss-of-function mutant"
      ],
      "replicates": true,
      "variant_controls": [
        "known pathogenic variants"
      ]
    },
    "statistics": {
      "p_value": "< 0.01",
      "effect_size": "40% reduction in activity"
    },
    "oddsPath": 5.2,
    "results": {
      "step_1": {
        "question": "Does the paper clearly define the disease mechanism relevant to the functional assay being described for this variant?",
        "extracted_info": "Yes, the paper describes that PHOX2B is a transcription factor involved in the development and function of neurons. The p.R98W variant is shown to reduce enzyme activity, which may contribute to the pathogenesis of certain neurodevelopmental disorders.",
        "judgment": true,
        "reasoning": "The paper explicitly describes the molecular basis of PHOX2B's role in neuron development and function, and how this variant impacts enzyme activity.",
        "next_step_or_outcome": "Proceed to Step 2"
      },
      "step_2": {
        "question": "Does the general class of assay used for this variant (enzyme activity assay) effectively model or reflect the disease pathogenesis/mechanism defined in Step 1?",
        "judgment": true,
        "reasoning": "Enzyme activity assays are commonly used to study the function of transcription factors, and reductions in activity can be indicative of loss-of-function mutations that contribute to disease.",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      "step_3": {
        "question_3a": {
          "question_1": "Were basic controls included for this assay?",
          "question_2": "Did the paper explicitly state that multiple replicates were used for the experiments?",
          "judgment_1": true,
          "judgment_2": true,
          "next_step_or_outcome": "Proceed to Step 4"
        },
        "question_3b": {
          "question": "Has the specific instance of the assay been broadly accepted historically or previously validated in other studies?",
          "judgment": true,
          "next_step_or_outcome": "NA"
        }
      },
      "step_4": {
        "question_4a": {
          "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
          "judgment": true,
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        "question_4b": {
          "question": "How many total benign/pathogenic variant controls were used across the entire study?",
          "judgment": 15,
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        "question_4c": {
          "information": "OddsPath calculated for this variant: 5.2",
          "judgment": true,
          "reasoning": "OddsPath of 5.2 is moderate according to ACMG guidelines."
        }
      },
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The functional data from the enzyme activity assay for the p.R98W variant in PHOX2B shows a moderate reduction (5.2 OddsPath) in activity, providing PS3_moderate evidence of pathogenicity."
    }
  },
  {
    "paper_title": "Paper 2",
    "gene": "PTEN",
    "protein": "Phosphatase",
    "variant": "p.E158A",
    "assay_type": "Protein interaction assay",
    "controls": {
      "basic_controls": [
        "empty vector"
      ],
      "replicates": true,
      "variant_controls": []
    },
    "statistics": {},
    "results": {
      "step_1": {
        "question": "Does the paper clearly define the disease mechanism relevant to the functional assay being described for this variant?",
        "extracted_info": "Yes, the paper describes that PTEN is a phosphatase involved in cellular signaling pathways. The p.E158A variant has altered protein interactions which may contribute to tumorigenesis.",
        "judgment": true,
        "reasoning": "The paper explicitly describes the molecular basis of PTEN's role in cell signaling and how this variant impacts protein interactions.",
        "next_step_or_outcome": "Proceed to Step 2"
      },
      "step_2": {
        "question": "Does the general class of assay used for this variant (protein interaction assay) effectively model or reflect the disease pathogenesis/mechanism defined in Step 1?",
        "judgment": true,
        "reasoning": "Protein interaction assays are commonly used to study changes in protein function that can lead to tumorigenesis.",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      "step_3": {
        "question_3a": {
          "question_1": "Were basic controls included for this assay?",
          "question_2": "Did the paper explicitly state that multiple replicates were used for the experiments?",
          "judgment_1": true,
          "judgment_2": true,
          "next_step_or_outcome": "Proceed to Step 4"
        },
        "question_3b": {
          "question": "Has the specific instance of the assay been broadly accepted historically or previously validated in other studies?",
          "judgment": true,
          "next_step_or_outcome": "NA"
        }
      },
      "step_4": {
        "question_4a": {
          "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
          "judgment": false,
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        "question_4b": {
          "question": "How many total benign/pathogenic variant controls were used across the entire study?",
          "judgment": 5,
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        "question_4c": {
          "information": "No direct OddsPath was calculated or inferred.",
          "judgment": true,
          "reasoning": "No direct OddsPath was provided, but since there were only 5 total variant controls and the assay was not statistically analyzed, this provides Max PS3_supporting evidence."
        }
      },
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The protein interaction assay for the p.E158A variant in PTEN shows altered interactions, providing PS3_supporting evidence of pathogenicity. However, since there were only 5 total variant controls and no statistical analysis was performed, this provides Max PS3_supporting evidence."
    }
  }
]